Jellyfish Derived Ingredients for Drugs and Nutraceuticals

Dear Colleagues,

Jellyfish biodiversity holds potential for drug discovery due to the unique and often complex compounds found in their biochemical composition. Jellyfish’s adaptation strategies to different marine environments, including symbiosis, enhance their biochemical complexity and increase the possibility that jellyfish biodiversity can contribute to drug discovery.

Some compounds found in jellyfish are being investigated for their nutraceutical properties; however, few jellyfish species have been explored for their potential health benefits. Nutraceuticals are food or food products that provide health benefits beyond basic nutrition, and jellyfish compounds such as collagen, jellyfish peptides, fatty acids, mucin, and other still unexplored compounds could have yet unknown bioactivities.

The study of jellyfish compounds can also have applications in biotechnology, such as the development of molecular tools and biosensors. While jellyfish biodiversity offers exciting possibilities, exploring these potential drug sources is a complex process. Isolation, characterization, and appropriate testing compounds for safety and efficacy are still fields in need of further research. Additionally, ethical considerations and conservation efforts are crucial to ensure sustainable practices in the study and harvesting of jellyfish for scientific purposes.

As a positive consequence of these application-oriented research activities, increased interest in jellyfish species can lead to greater knowledge of their biology and the critical role that they play in supporting marine biodiversity, the evolutionary genomics of jellyfish and symbionts, and the use of jellyfish as a model organism in cutting-edge ocean science research.

The focus of this Special Issue will be to collect research articles that add experimental tests highlighting the potential of natural products originating from cnidaria, particularly from jellyfish-forming species, that are active as nutraceuticals and lead compounds in drug discovery.

Dr. Antonella Leone
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• jellyfish
• blue-biotechnology
• bioactive compounds
• antioxidants
• anticancer
• anti-inflammatory
• nutraceuticals
• zoxanthelatea jellyfish
• functional novel foods
• drug discovery